珀莱雅(603605) - 2019 Q3 - 季度财报

Financial Performance - Operating income for the first nine months was approximately ¥2.08 billion, representing a year-on-year increase of 33.35%[5] - Net profit attributable to shareholders of the listed company was approximately ¥240 million, up 32.04% from the previous year[5] - Basic earnings per share increased by 31.87% to ¥1.20 per share[6] - Diluted earnings per share rose by 30.77% to ¥1.19 per share[6] - The company reported a total comprehensive income of ¥64,517,125.63 for Q3 2019, compared to ¥52,892,468.79 in Q3 2018[28] - The company’s net profit for the first three quarters of 2019 was ¥233,171,465.08, up 28.5% from ¥181,437,019.40 in the first three quarters of 2018[27] - The net profit for Q3 2019 was ¥90,129,789.30, up 60.0% from ¥56,356,192.93 in Q3 2018[31] Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥2.70 billion, a decrease of 5.46% compared to the end of the previous year[5] - Total liabilities decreased from CNY 1,161,731,820.18 to CNY 820,951,257.68, a reduction of approximately 29.3%[19] - Current liabilities totaled CNY 748,995,003.95, down from CNY 1,034,656,960.19, representing a decrease of about 27.7%[19] - Non-current liabilities decreased from CNY 127,074,859.99 to CNY 71,956,253.73, a decline of approximately 43.4%[19] - Total equity attributable to shareholders increased from CNY 1,694,310,463.85 to CNY 1,865,143,491.44, reflecting a growth of about 10.1%[20] Cash Flow - The net cash flow from operating activities for the first nine months was approximately ¥72.65 million, a decrease of 61.02% compared to the previous year[5] - The net cash flow from operating activities was 72,650,491.31 CNY, a decrease of 61% compared to 186,372,616.78 CNY in the same period last year[34] - Total cash inflow from operating activities reached 2,143,925,918.00 CNY, up from 1,809,714,207.30 CNY, representing an increase of approximately 18.5%[34] - Cash outflow from operating activities totaled 2,071,275,426.69 CNY, compared to 1,623,341,590.52 CNY, marking a rise of about 27.7%[34] Investments and Expenses - Research and development expenses grew by 33.82% to ¥47,321,735.02 from ¥35,363,534.33, reflecting enhanced investment in new product development and formula upgrades[13] - Long-term equity investments increased by 182.96% to ¥20,364,126.41 from ¥7,196,757.47, due to new investments in joint ventures[12] - The company reported non-operating income of approximately ¥5.09 million from government subsidies related to normal business operations[7] - The company reported a decrease in financial expenses, showing a net income of -¥1,997,893.48 in Q3 2019 compared to -¥1,805,061.75 in Q3 2018[30] Shareholder Information - The total number of shareholders at the end of the reporting period was 9,770, with the largest shareholder holding 36.09% of the shares[9] - Unallocated profits rose from CNY 634,448,228.13 to CNY 787,919,789.22, an increase of approximately 24.2%[20]